JP2002201141A5 - - Google Patents

Download PDF

Info

Publication number
JP2002201141A5
JP2002201141A5 JP2001116710A JP2001116710A JP2002201141A5 JP 2002201141 A5 JP2002201141 A5 JP 2002201141A5 JP 2001116710 A JP2001116710 A JP 2001116710A JP 2001116710 A JP2001116710 A JP 2001116710A JP 2002201141 A5 JP2002201141 A5 JP 2002201141A5
Authority
JP
Japan
Prior art keywords
ifn
activity
sample
cells
determined
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001116710A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002201141A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2001116710A priority Critical patent/JP2002201141A/ja
Priority claimed from JP2001116710A external-priority patent/JP2002201141A/ja
Priority to PCT/JP2001/008390 priority patent/WO2002036153A1/ja
Priority to KR1020027008401A priority patent/KR100830268B1/ko
Priority to US09/962,625 priority patent/US6773701B2/en
Priority to EP01972507A priority patent/EP1329223A4/en
Priority to CA002395324A priority patent/CA2395324A1/en
Priority to TW090125438A priority patent/TWI283582B/zh
Publication of JP2002201141A publication Critical patent/JP2002201141A/ja
Priority to US10/777,081 priority patent/US7189389B2/en
Publication of JP2002201141A5 publication Critical patent/JP2002201141A5/ja
Pending legal-status Critical Current

Links

JP2001116710A 2000-10-27 2001-04-16 蛋白質合成抑制遺伝子の発現増強剤 Pending JP2002201141A (ja)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP2001116710A JP2002201141A (ja) 2000-10-27 2001-04-16 蛋白質合成抑制遺伝子の発現増強剤
CA002395324A CA2395324A1 (en) 2000-10-27 2001-09-26 Expression potentiator for protein synthesis regulatory gene
EP01972507A EP1329223A4 (en) 2000-10-27 2001-09-26 EXPRESSION AMPLIFIER FOR PROTEIN SYNTHESIS OF REGULATORY GENES
KR1020027008401A KR100830268B1 (ko) 2000-10-27 2001-09-26 단백질 합성 억제 유전자의 발현 증강제
US09/962,625 US6773701B2 (en) 2000-10-27 2001-09-26 Expression enhancer for protein synthesis inhibitory genes
PCT/JP2001/008390 WO2002036153A1 (en) 2000-10-27 2001-09-26 Expression potentiator for protein synthesis regulatory gene
TW090125438A TWI283582B (en) 2000-10-27 2001-10-15 Expression potentiator for protein synthesis regulatory gene
US10/777,081 US7189389B2 (en) 2000-10-27 2004-02-13 Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-328539 2000-10-27
JP2000328539 2000-10-27
JP2001116710A JP2002201141A (ja) 2000-10-27 2001-04-16 蛋白質合成抑制遺伝子の発現増強剤

Publications (2)

Publication Number Publication Date
JP2002201141A JP2002201141A (ja) 2002-07-16
JP2002201141A5 true JP2002201141A5 (cg-RX-API-DMAC7.html) 2008-05-15

Family

ID=26602905

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001116710A Pending JP2002201141A (ja) 2000-10-27 2001-04-16 蛋白質合成抑制遺伝子の発現増強剤

Country Status (7)

Country Link
US (2) US6773701B2 (cg-RX-API-DMAC7.html)
EP (1) EP1329223A4 (cg-RX-API-DMAC7.html)
JP (1) JP2002201141A (cg-RX-API-DMAC7.html)
KR (1) KR100830268B1 (cg-RX-API-DMAC7.html)
CA (1) CA2395324A1 (cg-RX-API-DMAC7.html)
TW (1) TWI283582B (cg-RX-API-DMAC7.html)
WO (1) WO2002036153A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
JP4629964B2 (ja) * 2003-09-12 2011-02-09 株式会社林原生物化学研究所 ウシの消化器疾患治療剤
CN101031655A (zh) 2004-07-26 2007-09-05 陶氏环球技术公司 通过株工程改进蛋白表达的方法
EP1867340A4 (en) 2005-03-10 2009-12-23 Hayashibara Biochem Lab THERAPEUTIC AGENT FOR TREATING DISEASES IN THE BOVINE DIGESTIVE SYSTEM
JPWO2007037098A1 (ja) * 2005-09-27 2009-04-02 株式会社林原生物化学研究所 繁殖障害改善剤
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9394571B2 (en) 2007-04-27 2016-07-19 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
CN104056254A (zh) * 2013-03-18 2014-09-24 赛德医药科技股份有限公司 用以降低肝炎病患复发率的组合物
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5142199B2 (cg-RX-API-DMAC7.html) 1972-09-04 1976-11-13
GB2016015B (en) 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
JPS5639022A (en) 1979-09-05 1981-04-14 Hayashibara Biochem Lab Inc Preparation of vaccine
JPS5654158A (en) 1979-10-09 1981-05-14 Hitachi Ltd Control system for call waiting
JP2838800B2 (ja) 1989-09-02 1998-12-16 株式会社林原生物化学研究所 減感作剤
US5503828A (en) * 1992-02-10 1996-04-02 Interferon Sciences, Inc. Alpha interferon composition and method for its production from human peripheral blood leukocytes
JP3232488B2 (ja) 1992-08-20 2001-11-26 株式会社林原生物化学研究所 プルラン高含有物とその製造方法並びに用途
US5780021A (en) * 1993-03-05 1998-07-14 Georgetown University Method for treating type 1 diabetes using α-interferon and/or β-i
JPH07163368A (ja) 1993-12-15 1995-06-27 Hayashibara Biochem Lab Inc 組換えdnaとその組換えdnaを含む形質転換体
EP0785276A4 (en) 1994-09-29 2002-01-09 Ajinomoto Kk MODIFICATION OF A PEPTIDE AND A PROTEIN
JP3467515B2 (ja) * 1994-11-01 2003-11-17 財団法人ルイ・パストゥール医学研究センター インターフェロン活性の測定法
MY125300A (en) * 1999-02-26 2006-07-31 Inst Of Molecular And Cell Biology Synergistic combination for treatment of viral-mediated diseases

Similar Documents

Publication Publication Date Title
Lonberg-Holm et al. Unrelated animal viruses share receptors
Fife et al. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection: results of an international, multicenter, double-blind, randomized clinical trial
Amano et al. Salivary receptors for recombinant fimbrillin of Porphyromonas gingivalis
DE60119734D1 (de) Hpv-e7 zur behandlung von menschlichem papillomavirus
JP2002513768A5 (cg-RX-API-DMAC7.html)
Lucht et al. Entamoeba gingivalis in human immunodeficiency virus type 1-infected patients with periodontal disease
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
Jones et al. Between‐subject and within‐subject variations in the pharmacokinetics of ethanol.
JP2006511450A (ja) 治療用ウイルスの投与
AR035867A1 (es) Una particula semejante a un virus hcv formada por una proteina de envoltura de hcv, un metodo para formar dicha particula, un medicamento que la contiene, una vacuna, un metodo de deteccion, un kit de diagnostico, el uso de cepas de hansenula o saccharomyces para la expresion de una proteina hcv, e
Wolcott et al. Exposure to ozone reduces influenza disease severity and alters distribution of influenza viral antigens in murine lungs
Favié et al. Pharmacokinetics of favipiravir during continuous venovenous haemofiltration in a critically ill patient with influenza
Barteling A simple method for the preparation of agarose
Rezkalla et al. Effect of indomethacin in the late phase of coxsackievirus myocarditis in a murine model
Martin et al. Comparative bioavailability of two furosemide formulations in humans
US20100267616A1 (en) Acute respiratory syndromes
Ruzicka et al. A probable case of rotavirus exanthem
Gall Human papillomavirus infection and therapy with interferon
Youngner et al. Interferon production in mice by vesicular stomatitis virus
Weiner et al. Viral hemorrhagic fevers-a recurrent public health threat
Khanna et al. Regulation of vascular permeability by macrophage‐derived chemotactic factor produced in Japanese encephalitis
McLean et al. Infections with enteroviruses in Toronto, 1961
Giusti et al. Etiological, clinical and laboratory data of post-transfusion hepatitis: a retrospective study of 379 cases from 53 Italian hospitals
Pereira Occurrence of adenovirus type 21 in Great Britain
Flamenbaum Propranolol versus labetalol: interesting differences in efficacy